Rocket Pharmaceuticals, Inc.RCKTNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank38
3Y CAGR-18.0%
5Y CAGR-23.6%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-18.0%/yr
vs +6.0%/yr prior
5Y CAGR
-23.6%/yr
Recent acceleration
Acceleration
-24.0pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $77.56M | -52.6% |
| 2024 | $163.63M | +192.7% |
| 2023 | $55.90M | -60.2% |
| 2022 | $140.52M | -39.6% |
| 2021 | $232.69M | -21.7% |
| 2020 | $297.10M | +60.3% |
| 2019 | $185.38M | +66.5% |
| 2018 | $111.36M | +41.5% |
| 2017 | $78.72M | +164.2% |
| 2016 | $29.80M | - |